drugset / Trial / NCT04738838

Oxytocin on Cold Water Task Performance and Recovery

NCT04738838 ↗

RandomizedCrossoverQuadruple-blindPrevention

Summary

Naval Special Warfare (NSW) operators are exposed to a variety of extreme environmental conditions and intense physical demands. In addition to breathing high pressure gases at depth, prolonged cold water immersion and inadequate recovery from sustained physical exertion negatively impact individual and team performance. Biotechnologies that could mitigate the effects of cold as well as support physical recovery represent a significant unmet need for the NSW operational community. Oxytocin (OT) has a wide range of actions both locally in the brain and peripherally in the body including skeletal muscle. These peripheral effects can be mediated by classic ligand-receptor activation given the abundant expression of the oxytocin receptor in peripheral tissues, along with local expression of OT in peripheral tissues where it is likely to act in an autocrine manner. Exogenous OT via intranasal administration is FDA Investigational New Drug (IND)-approved and has been demonstrated as an easy and safe method to increase circulating OT concentrations that may augment actions on peripheral tissues.

Timeline

Start
2022-05-20
Primary completion
2022-07-29
Completion
2022-07-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 48 iu Intranasal

Indications

No indication recorded.